OQROGet OQRO Pro
Insider trade

Emergent Biosolutions (EBS)Director sold ~$49K

Keith Katkin, Director at Emergent Biosolutions, sold ~$49K of Emergent Biosolutions shares.

~$49K
Approx. value · 7,844 sh @ $6.30
86K
Holds after · shares reported
Traded
May 23, 2025
Filed
May 28, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 13, 2025InsiderCEO purchased ~$350K of EBS shares in the open market
  2. May 23, 2025 · this disclosureInsiderDirector sold ~$49K of EBS shares in the open market

What came next

  1. Aug 12, 2025InsiderDirector sold ~$68K of EBS shares in the open market
  2. Aug 15, 2025InsiderDirector sold ~$63K of EBS shares in the open market
  3. Sep 5, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Emergent Biosolutions

For Emergent Biosolutions, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EBS page.

Other recent filings by Keith Katkin, Director

The full history of Keith Katkin, Director is on the profile page.

How this filing works

Other disclosures at Emergent Biosolutions

Everything OQRO holds on this company is on its EBS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data